Latest Barbara Ann Karmanos Cancer Institute Stories
Abstract # 3179 SAN DIEGO, Oct.
ADDRESSING NATIONAL SHORTAGE OF MINORITY CORD BLOOD DETROIT, Oct. 22 /PRNewswire-USNewswire/ -- The J.P.
2010 Komen Detroit Race for the CureÂ® Accomplishments DETROIT, Sept. 23 /PRNewswire-USNewswire/ -- Susan G.
DETROIT, Sept. 15 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Center in Detroit was recently selected to be one of 50 sites in the United States to offer the new U.S.
BEVERLY HILLS, Calif., Sept. 8 /PRNewswire/ -- Tower Cancer Research Foundation, a nonprofit organization dedicated to cutting edge cancer therapy and research, will host the first in a series of free symposiums on October 19.
TROY, Mich., June 15 /PRNewswire/ -- CareTech Solutions (www.caretech.com), an information technology (IT) and Web products and services provider for more than 150 hospitals nationwide, announced today the appointment of Michael Duggan, Detroit Medical Center president and CEO; and Jay Rising, Detroit Medical Center executive vice president and CFO, to the CareTech Solutions board of directors.
CHICAGO, June 6 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, both in Detroit, and the Children's Hospital of Michigan/Detroit Medical Center, presented preliminary data that identified a potential link between Gilbert's Syndrome and the development of a specific subtype of childhood acute lymphoblastic leukemia (ALL).
CHICAGO, June 5 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented preliminary data that shows nitrogen-containing bisphosphonates, therapeutic agents used to promote bone health and inhibit resorption, may cause a slightly poorer survival rate in post-menopausal women with early stage breast cancer who take them for their anti-osteoporosis properties.
CHICAGO, June 5 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented data showing that by combining two treatment agents in the care of multiple myeloma patients, doctors can use higher dosages of chemotherapy before autologous stem cell transplant while alleviating painful and debilitating side effects like severe oral mucositis (mouth ulcers).
- A trick or prank.